Early clinical outcomes in children enrolled in human immunodeficiency virus infection care and treatment in lesotho

Pediatric Infectious Disease Journal

Volumn 29, Issue 4, 2010, Pages 340-345

  Leyenaar, Joanna K ^a,b   Novosad, Paul M ^a   Ferrer, Katheleen T ^a,b   Thahane, Lineo K ^a,b   Mohapi, Edith Q ^a,b   Schutze, Gordon E ^a   Kline, Mark W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Baylor College of Medicine Children's Foundation   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; COTRIMOXAZOLE; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; MULTIVITAMIN; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADOLESCENT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD CARE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG FATALITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LESOTHO; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MEDICAL RECORD REVIEW; MORTALITY; NEWBORN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

EID: 77950214393     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181bf8ecb     Document Type: Article

References (31)

1. Havens PL, Gibb DM; American Academy of Pediatrics Committee on Pediatric AIDS, Section on International Child Health. Increasing antiret-roviral drug access for children with HIV infection. Pediatrics. 2007;119: 838-845.
2. Kline MW. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics. 2006;117:1388-1393.
3. Makombe S, Libamba E, Mhango E, et al. Who is accessing antiretroviral therapy during national scale-up in Malawi? Trans R Soc Trop Med Hyg. 2006;100:975-979.
4. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
5. Goulder PJ, Jeena P, Tudor-Williams G, et al. Paediatric HIV infection: correlates of protective immunity and global perspectives in prevention and management. Br Med Bull. 2001;58:89-108.
6. Kline MW, Rugina S, Ilie M, et al. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir- containing highly active antiretroviral therapy. Pediatrics. 2007;119: e1116-e1120.
7. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899.
8. Jaspan HB, Berrisford AE, Boulle AM. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatr Infect Dis J. 2008;27:993-998.
9. Marazzi MC, Germano P, Liotta G, et al. Pediatric highly active antiretro-viral therapy in Mozambique: an integrated model of care. Minerva Pediatr. 2006;58:483-490.
10. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.
11. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatrics. 2007;7:13.
12. van Griensven J, De Naeyer L, Uwera J, et al. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatrics. 2008;8:39.
13. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Geneva, Switzerland: WHO Press; 2006. Available at: http://www.who.int/hiv/pub/ guidelines/paediatric020907.pdf.
14. Jaffar S, Grant AD, Whitworth J, et al. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull World Health Organ. 2004;82:462-469.
15. Morgan D, Mahe C, Mayanja B, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS. 2002;16:597-603.
16. Prendergast A, Tudor-Williams G, Jeena P, et al. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet. 2007; 370:68-80.
17. Taha TE, Graham SM, Kumwenda NI, et al. Morbidity among human immunodeficiency virus-1-infected and-uninfected African children. Pediatrics. 2000;106:E77.
18. World Health Organization Statistical Information System. Available at: http://www.who.int/whosis/en/.
19. Joint United Nations Programme on HIV/AIDS. UNAIDS Country Report: Lesotho, 2007. Available at:http://www.unaids.org/en/Regions-Countries/ Countries/lesotho.asp.
20. United Nations Development Program. Lesotho Information. Available at: http://www.undp.org.ls/Lesotho/default.php.
21. Siberry GK, Tessema S. Immune reconstitution syndrome precipitated by bacille Calmette Guerin after initiation of antiretroviral therapy. Pediatr Infect Dis J. 2006;25:648-649.
22. World Health Organization. The WHO Child Growth Standards, 2006. Available at: http://www.who.int/childgrowth/standards/en/.
23. Waters L, John L, Nelson M. Non-nucleoside reverse transcriptase inhibitors: a review. Int J Clin Pract. 2007;61:105-118.
24. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367:1335-1342.
25. Miller T, Easley KA, Zhang W, et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics. 2001;108:1287-1296.
26. Eley B, Davies M, Apolles P, et al. Antiretroviral treatment for children. S Afr Med J. 2006;96:988-993.
27. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. New Engl J Med. 2008;359:2233-2244.
28. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment program for HIV-infected children and their parents. S Afr Med J. 2004;94:643-646.
29. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis. 2007;44:599-604.
30. World Health Organization. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting, WHO Headquarters, Geneva, Switzerland, April 10-11, 2008. Available at: http://www.who.int/hiv/pub/ paediatric/art-meeting-april2008/en/index.html.
31. van der Sande MA, Schim van der Loeff MF, Aveika AA, et al. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr. 2004;37:1288-1294.